Clinical Trial Update: The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of fluconazole on the pharmacokinetics of fesoterodine in healthy subjects, sponsored by Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (Toviaz) (fesoterodine)
• Fluconazole (Diflucan) (fluconazole)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence | Phase 1 | Status: COMPLETED